Announced Sat, 10 Oct, 2026 · 17:26 IST

Compliance certificate for share demat filed for quarter ended Sep 2026

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+14.2%Reaction day

₹45.55

prior close

₹46.49

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+13.3% vs market

Pharmaceuticals peers, median of 167sector-0.1%+14.3% vs sector

On the reaction day the stock moved 13.3 pts more than Nifty Microcap 250 and 14.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+7.5

10m

+5.4

15m

+5.6

30m

+3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+14.2+0.8+13.3-0.1+14.3

Next day

+16.4+1.0+15.3-0.1+16.5

+11.3+1.7+9.6-0.3+11.6

+5.8+0.1+5.7-1.0+6.7

+0.8+0.8-0.0-0.8+1.6

+1.0-0.9+1.9-2.3+3.3

+3.2-4.5+7.7-4.7+7.9

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shelter Pharma submitted a routine compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ending 30 September 2026. The certificate, issued by their registrar Bigshare Services, confirms that no requests for dematerialisation or rematerialisation were received during the quarter, since all company shares are already held in demat form. The filing is available on the company website and is purely a regulatory compliance requirement.

Likely market impact

Routine compliance filing with no material impact on shareholders, business, or stock price.